Biggest News Aggregation in the World
📰 Vitro Diagnostics News

Page 7 - Vitro Diagnostics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vitro Diagnostics. Real-time updates on events, politics, business and more.

Global In Vitro Diagnostics Market to Reach $138.4 Billion, Globally by 2032: Allied Market Research

The global in vitro diagnostics market is expanding rapidly due to a surge in the number of diagnostic laboratories, rise in awareness regarding personalized medicine and early disease diagnosis, and growing prevalence of infectious and chronic diseases.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "In Vitro Diagnostics Market by Product and Services (Reagents and Kits, Instruments, Software, and Services), Technique, (Immunodiagn...
United Kingdom United States Hong Kong Intervenn Biosciences Pawan Kumar David Correa
Source: yahoo.com

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

08.11.2023 - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2023, and introduced ...
United States New York Eden Prairie Gary Maharaj Sundance Sirolimus Surmodics Inc

Surmodics (SRDX) Set to Announce Quarterly Earnings on Wednesday

Surmodics (NASDAQ:SRDX – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, November 8th. Analysts expect Surmodics to post earnings of $0.16 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Surmodics Price Performance […]
United States Gamco Investors Yousif Capital Management Surmodics Inc Group Plc Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Analysts Set Expectations for Surmodics, Inc.'s Q1 2025 Earnings (NASDAQ:SRDX)

Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Equities researchers at Zacks Research boosted their Q1 2025 earnings per share (EPS) estimates for Surmodics in a research note issued on Tuesday, October 31st. Zacks Research analyst D. Dey now anticipates that the company will post earnings of ($0.22) per share for the quarter, up from their […]
United States Nisa Investment Advisors Tower Research Capital Needham Company Zacks Research Surmodics Company Profile

Global Oligonucleotide Synthesis Markets Research Report 2023-2027: RNA Based Vaccines, Genomic Blizzard, & Antisense Revival at the Forefront of Growth and Developments

/PRNewswire/ -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to...
Primerdesign Novacyt Siemens Healthineers Eurogentec Kaneka Laura Wood Camena Bioscience Ajinomoto Bio Pharma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science